{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:34:36Z","timestamp":1762979676135},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,3,15]],"date-time":"2009-03-15T00:00:00Z","timestamp":1237075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00296-009-0875-x","type":"journal-article","created":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T05:04:10Z","timestamp":1237007050000},"page":"1435-1439","source":"Crossref","is-referenced-by-count":13,"title":["Serum homocysteine level in patients with ankylosing spondylitis"],"prefix":"10.1007","volume":"29","author":[{"given":"Bedriye Mermerci","family":"Ba\u015fkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Sivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lale Akbulut","family":"Aktekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin Pekin","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00fcr\u015fat","family":"\u00d6zoran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Bodur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,15]]},"reference":[{"key":"875_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J Jr et al (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131:363\u2013375","journal-title":"Ann Intern Med"},{"issue":"13","key":"875_CR2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS et al (1995) A quantative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274(13):1049\u20131057","journal-title":"JAMA"},{"key":"875_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/hrt.82.4.448","volume":"82","author":"PH Whincup","year":"1999","unstructured":"Whincup PH, Refsum H, Perry IJ et al (1999) Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 82:448\u2013454","journal-title":"Heart"},{"issue":"19","key":"875_CR4","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","volume":"274","author":"O Nygard","year":"1995","unstructured":"Nygard O, Vollset SE, Refsum H et al (1995) Total plazma homocysteine and cardiovascular risk profile. JAMA 274(19):1526\u20131533","journal-title":"JAMA"},{"key":"875_CR5","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves M, D\u2019Almeida V, Guerra-Shinohara EM et al. (2007) Homocysteine and lipid profile in children with juvenile idiopathic arthritis. Pediatr Rheumatol. doi: 10.1186\/1546-0096-5-2","DOI":"10.1186\/1546-0096-5-2"},{"key":"875_CR6","first-page":"1109","volume-title":"Rheumatology","author":"J Rveille","year":"2008","unstructured":"Rveille J (2008) Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 4th edn. Elsevier, Spain, pp 1109\u20131114","edition":"4"},{"issue":"2","key":"875_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/CS20040326","volume":"109","author":"H Divecha","year":"2005","unstructured":"Divecha H, Sattar N, Rumley A et al (2005) Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci 109(2):171\u2013176","journal-title":"Clin Sci"},{"issue":"Suppl 3","key":"875_CR8","doi-asserted-by":"crossref","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M et al (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl 3):iii8\u2013iii18","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"875_CR9","first-page":"2374","volume":"31","author":"N Hornung","year":"2004","unstructured":"Hornung N, Ellingsen T, Stengard Pedersen K et al (2004) Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and effect of low dose folic acid supplement. J Rheumatol 31(12):2374\u20132381","journal-title":"J Rheumatol"},{"issue":"4","key":"875_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"key":"875_CR11","first-page":"2286","volume":"21","author":"S Garret","year":"1994","unstructured":"Garret S, Jenksion T, Kennedy L et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"issue":"12","key":"875_CR12","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garret S, Whitelock HC et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281\u20132285","journal-title":"J Rheumatol"},{"issue":"4","key":"875_CR13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00296-003-0432-y","volume":"25","author":"Y Akko\u00e7","year":"2005","unstructured":"Akko\u00e7 Y, Karatepe AG, Akar S et al (2005) The Turkish versions of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280\u2013284","journal-title":"Rheumatol Int"},{"key":"875_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10067-004-0968-6","volume":"24","author":"B Yan\u0131k","year":"2005","unstructured":"Yan\u0131k B, Kurtai\u015f G\u00fcrsel Y, Kutlay \u015e et al (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the T\u00fcrkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24:41\u201347","journal-title":"Clin Rheumatol"},{"issue":"3","key":"875_CR15","first-page":"441","volume":"25","author":"SL Morgan","year":"1998","unstructured":"Morgan SL, Baggott JE, Lee JY et al (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol 25(3):441\u2013446","journal-title":"J Rheumatol"},{"key":"875_CR16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10067-006-0396-x","volume":"26","author":"JC Wei","year":"2007","unstructured":"Wei JC, Jan MS, Yu CT et al (2007) Plasma homocysteine status in patients with ankylosing spondylitis. Clin Rheumatol 26:739\u2013742","journal-title":"Clin Rheumatol"},{"issue":"8","key":"875_CR17","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.4049\/jimmunol.160.8.3737","volume":"160","author":"MM Chilvers","year":"1998","unstructured":"Chilvers MM, Wordsworth P, Stubbs A et al (1998) TCR usage by homocysteine-specific human CTL. J Immunol 160(8):3737\u20133742","journal-title":"J Immunol"},{"key":"875_CR18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/eji.1830260707","volume":"26","author":"XM Gao","year":"1996","unstructured":"Gao XM, Wordsworth P, McMichael AJ et al (1996) Homocysteine modification of HLA antigens and its immunological consequences. Eur J Immunol 26:1443\u20131450","journal-title":"Eur J Immunol"},{"issue":"4","key":"875_CR19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/art.1780400418","volume":"40","author":"R Roubenoff","year":"1997","unstructured":"Roubenoff R, Dellaripa P, Nadeau MR et al (1997) Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40(4):718\u2013722","journal-title":"Arthritis Rheum"},{"issue":"2","key":"875_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/ard.58.2.79","volume":"58","author":"CJ Haagsma","year":"1999","unstructured":"Haagsma CJ, Blom HJ, van Riel PL et al (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58(2):79\u201384","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"875_CR21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s10067-006-0380-5","volume":"26","author":"D Malesci","year":"2007","unstructured":"Malesci D, Niglio A, Mennillo GA et al (2007) High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 26(5):710\u2013714","journal-title":"Clin Rheumatol"},{"issue":"12","key":"875_CR22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00296-008-0687-4","volume":"28","author":"L Gonzalez-Lopez","year":"2008","unstructured":"Gonzalez-Lopez L, Sancez-Hernandez JD, Aguilar Chavez EA et al (2008) Hyperhomocysteinemi in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 28(12):1223\u20131228","journal-title":"Rheumatol Int"},{"issue":"21","key":"875_CR23","first-page":"5879","volume":"49","author":"EH Broxson","year":"1989","unstructured":"Broxson EH, Stork LC, Allen RH et al (1989) Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res 49(21):5879\u20135883","journal-title":"Cancer Res"},{"issue":"7","key":"875_CR24","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.20375","volume":"50","author":"G Jansen","year":"2004","unstructured":"Jansen G, van der Heijden J, Oerlemans R et al (2004) Sulfasalazine is a potent inhibitor of the reduced folat carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. Arthritis Rheum 50(7):2130\u20132139","journal-title":"Arthritis Rheum"},{"key":"875_CR25","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0006-2952(92)90079-X","volume":"44","author":"J Zimmerman","year":"1992","unstructured":"Zimmerman J (1992) Drug interactions in intestinal transport of folic acid and methotrexate. Biochem Pharmacol 44:1839\u20131842","journal-title":"Biochem Pharmacol"},{"key":"875_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1172\/JCI108921","volume":"61","author":"J Selhub","year":"1978","unstructured":"Selhub J, Dhar GJ, Rosenberg IH (1978) Inhibition of folat enzyms by sulfasalazine. J Clin Invest 61:221\u2013224","journal-title":"J Clin Invest"},{"key":"875_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj2820197","volume":"282","author":"JE Baggott","year":"1992","unstructured":"Baggott JE, Morgan SL, Ha T et al (1992) Inhibition of folat-dependent enzyms by non-steroidal anti-inflammatory drugs. Biochem J 282:197\u2013202","journal-title":"Biochem J"},{"issue":"8","key":"875_CR28","first-page":"1615","volume":"29","author":"OK Jensen","year":"2002","unstructured":"Jensen OK, Rasmussen C, Mollerup F et al (2002) Hyper homocysteinemi in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation. J Rheumatol 29(8):1615\u20131618","journal-title":"J Rheumatol"},{"issue":"2","key":"875_CR29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/03009740510026922","volume":"35","author":"MA Lopez-Olivo","year":"2006","unstructured":"Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A et al (2006) Factors associated with hyperhomocysteinaemi in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112\u2013116","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"875_CR30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA et al (2004) Cardiovascular risk profile of patients with spondyloarthropaties, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34(3):585\u2013592","journal-title":"Semin Arthritis Rheum"},{"key":"875_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.52.3.174","volume":"52","author":"K Lehtinen","year":"1993","unstructured":"Lehtinen K (1993) Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 52:174\u2013176","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0875-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-0875-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0875-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T16:52:29Z","timestamp":1710175949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-0875-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,15]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-0875-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,15]]}}}